This study examines the clinical relevance of tissue engineering integrating gene therapy and polymer science to bone regeneration. Bilateral maxillary defects (3 Â 1.2 cm 2 ) in 20 miniature swine were bridged with a bioresorbable internal splint. Constructs were created using ex vivo adenovirus bone morphogenetic protein (BMP)-2-mediated gene transfer to the expanded bone marrow mesenchymal stem cells (MSCs) 7 days before implantation. Controls were performed using adenovirus b-galactosidase. The BMP-2 cell/construct displayed white solid bone formation after 3 months. Meanwhile, the hematoxylin and eosin and Von Kossa stains demonstrated exhibited mature woven bone with good mineralization. Additionally, three-dimensional computer tomography imaging revealed a nearly complete infraorbital rim repair. Quantitative analysis demonstrated a significant difference (Po0.001) in bone formation. Finally, biomechanical testing revealed no statistically significant difference in the maximal compressive strength of new bone formed by BMP-2 cell constructs and the normal maxilla. The data evidenced de novo bone formation capable of sustaining axial compressive loads. The measurement results showed that ex vivo replication defective adenovirusmediated human BMP-2 gene transfer to MSCs enhances autologous bone formation in the repair of maxillary defects. Gene Therapy
Introduction
Over one million surgical procedures involving bone and cartilage repair are performed annually in the United States. 1 Autologous bone grafts are frequently used in these procedures. However, harvesting bone for grafting is an invasive and occasionally morbid procedure requiring an additional operative site. Allogenic bone grafting has limited usefulness because of the risks of immunological rejection and the transmission of infectious disease. Additional drawbacks include the propensity of bone graft to resorb, difficulty in shaping bone graft to fit the osseous defect, and insufficient bone graft volume to fill the defect completely. Demineralized bone powder 2 and biocompatible bone substitutes 3 displayed unsatisfactory results owing to their inability to repair critical sized bone defects.
Recently, tissue engineering has achieved some success in creating functional tissue using biocompatible and biodegradable polymers seeded with living cells. 1 Culturing osteoblasts onto polyglycolic acid/polylactic acid (PGA/PLA) fiber mesh has demonstrated that it is possible to fabricate osteoblast-PGA/PLA constructs. Furthermore, implantation of this construct into an animal host can generate new bone composition whose final morphology is based on the shape of the polymer scaffold. In the experience of the author, this construct triggered a strong cellular immune response and failed in the immunocompetent animal model.
Bone marrow mesenchymal stromal stem cells (MSCs) have displayed considerable potential for bone repair. MSCs are pluripotent progenitor cells with the ability for self-renewal and the generation of multiple mesodermal tissue types. 4 The osteogenic potential of marrowderived MSC is well known as evidenced by bone formation following in vivo transplantation of MSCs. [5] [6] [7] [8] [9] [10] Bone morphogenetic protein (BMP) has been demonstrated to trigger the development of osteoblasts from MSCs. [11] [12] [13] [14] BMP-2 gene transfer into MSCs induced differentiation of stem cells into an osseous lineage that formed bone in vivo. 12 This investigation examined whether this strategy could be used to repair a critical size membranous bone defect. To answer this question, repair of maxillary bone defects in miniature swine was assessed using BMP-2 gene engineered autologous MSCs.
Results

Recombinant adenovirus construction with human BMP-2 expression
These two recombinant adenoviruses were supplied with deletion only in the El region of the genome. The E3 region of the virus genome was deliberately retained intact on the vectors owing to evidence that the E3 proteins of the virus inhibit the host immune response. 15 When titered in 293 cells, the viral lysate of the vectors is 10 8 plaque-forming units (PFU) per milliliter. Detecting the coding product of BMP-2 can be used to assess the expression of human BMP-2 gene in MSCs, mediated by adenovirus BMP-2 gene transfer. The assay employed a specific monoclonal Ab against BMP-2. Since BMP-2 is a secretory growth factor, conditioned medium from virus-transduced cells was used as a starting material. Following immunoprecipitation and Western blotting, a specific band of molecular weight 21 kDa was detected from the conditioned medium from adenovirus-BMP-2-transduced MSCs. This 21 kDa band did not appear in the supernatant of the cultured medium from adenovirus-bgal-transduced MSCs. The adenovirusmediated BMP gene is well expressed and processed in MSCs because the molecular weight of the secreted BMP-2 indicated a mature status without any prepeptide form ( Figure 1 ).
Maxillary surgery and harvested infraorbital rim sample
Bilateral maxillary defects of 3 Â 1.2 cm 2 in miniature swine were created by removing bone and periosteum. The defects contained no osteoinductive tissues ( Figure  2a and b) . To bridge the defect, a bioresorbable polylactic acid plate (PLLA plate) was used as an internal splint to prevent soft tissue invagination into the defect ( Figure  2c ). Then, 3 ml of collagen type I-cell mix construct was slowly gelled and implanted to fill each defect ( Figure  2d ). The miniature swine quickly recovered from surgery without complications. Moreover, the infraorbital operated sites healed well. The area of bony healing gradually hardened on palpation. At 3 months after construct implantation, the miniature swine were sacrificed and the maxillary infraorbital region was harvested. Visible bony formation was noted at the defect site implanted with BMP-2 cell constructs (Figure 3b ) upon removal of all the soft tissue around the reconstructed areas. In the bgal cell construct control, findings included islands of bone formation with variable thickness and marked notching in the infraorbital rim (Figure 3a) . A block of bone formation was noted at the experimental site, but not at the control site.
Three-dimensional computer tomography imaging
Three-dimensional computer tomography (3D CT) imaging studies were conducted for each sample immediately after harvesting. The image revealed the complete repair of the defects implanted with BMP-2 cell construct at 3 months after implantation (Figure 4b) . Moreover, the entire regenerated maxilla remained in its original position. However, small islands of bone formation were observed in the bgal cell construct controls, with the defects remaining unrepaired (Figure 4a ). Quantitative analysis with Analyzer s software (Boston, MA, USA) demonstrated a significant difference .
Histological examination
Histological studies of samples with hematoxylin and eosin (HE) staining demonstrated cancellous bone formation at the defects implanted with BMP-2 cell constructs. Specifically, mature woven de novo bone was observed at the defects ( Figure 5a ). High-magnification microscopy revealed osteoblasts in the peripheral areas of newly formed bone. Furthermore, stained hallow was observed in the cell cytoplasm. Finally, Von Kossa assay revealed strongly positive staining in the repaired defect of BMP-2 cell implantation, indicating good mineralization ( Figure 5b ).
Biomechanical testing
Biomechanical properties were compared between the bone harvested from the experimental BMP-2 cell construct group 3 months in vivo and normal maxillary bone. The comparison results showed that both types of bones shared very similar biomechanical properties. Specifically, the newly formed bones and normal maxilla bones shared similar maximal compressive strength (80.62478.365 versus 81.64475.497 MPa, P¼0.751), with only a 1.2% difference. Furthermore, the effect size of this difference was just 0.19, considered by Cohen 16 to be small. The analysis indicated that newly formed bone in BMP-2 cell repaired defects shared strong biomechanical properties, such as the compression modulus (MPa), with normal maxillary bones. Irregular islands of new bone formation were noted in the control. This work was unable to conduct biomechanical testing because the thickness of bone in the control site was irregular and less than 2 mm.
Immunohistochemistry for adenovirus hexon protein
Specific Ab against adenovirus hexon protein was used in immunohistochemistry studies to seek remnants of adenovirus in the healed constructs. The analytical results revealed positive staining in BMP-2 cell constructs in vitro (Figure 6a ). However, no hexon protein was found in the repaired defects 3 months following implantation with BMP-2 cell constructs (Figure 6b ).
This phenomenon indicated that adenoviral vectors were cleared in vivo after 3 months. No evidence 
Discussion
Since the cloning of the genes of the BMP family, recombinant-DNA technology had made large quantities of individual BMP proteins available. Yasko et al, 17 was the first to demonstrate the effects of recombinant human BMP-2 on bone formation using a rat segmental femoraldefect model. Similar subsequent investigations have been performed in sheep femur, 18 canine spine, and mandible models. [19] [20] [21] [22] Although studies in which BMP protein is implanted directly to a defective area have achieved encouraging results, a large amount of protein (up to milligram quantities) is generally required to stimulate significant new bone formation in vivo. This requirement for large quantities of protein increases the risk of unwanted side effects. Additionally, the lack of a system to continuously deliver proteins 23 may hinder this approach. Recombinant BMP-2 displays great potential in bone repair; however, FDA approval of recombinant BMP-2 protein is currently limited to small dental defects, as commercial uses emphasize the importance of designing more stable and effective procedures for BMP-2 application.
This investigation adopted an alternative method for inducing bone formation, specifically a strategy combining BMP-2 gene transfer and autologous MSCs. The experimental results demonstrated that this strategy achieved complete repair of the maxillary bone defect with BMP-2 gene-transferred MSCs. This study thus confirmed that ex vivo gene therapy by adenovirus BMP-2 transduction could induce and enhance maxillofacial bone regeneration. Notably, the osteogenic periosteum around the maxilla was removed. Maxillary defects 3 Â 1.2 cm 2 were created bilaterally. The BMP-2 cell construct site displayed complete white solid bone formation, while the bgal cell construct site revealed an infraorbital notch in which the defect was not repaired. Additionally, 3D CT imaging revealed a nearly complete infraorbital rim repair in the experimental site. The histology indicated the presence of mature woven bone with well mineralization. Finally, the biomechanical test (maximal compressive strength) revealed no statistically significant difference between the new bone formed by BMP-2 cell construct and the normal maxillary bone. The data showed de novo bone formation with qualities comparable to normal maxillary bone, and thus capable of sustaining gravity loading and resisting peripheral soft tissue invagination.
Periosteum explant culture cells have been demonstrated to be able to be tissue-engineered into bone-like tissue. [24] [25] [26] [27] However, the slow expansion rates of periosteum explant culture cells render them vulnerable to enzymatic digestion. Difficult access to periosteum may limit the clinical application of periosteal cells in tissueengineered bone. However, MSCs are not subject to enzymatic digestion and are readily expandable in a monolayer culture in vitro. 28 MSCs can be obtained by minimally invasive aspiration, making them a sensible choice for clinical application.
Collagen is considered one of the most useful biomaterials for growth factor delivery owing to its excellent biocompatibility and safety. 29 Rapid resorption of collagen within 2 weeks facilitates bone formation when BMP-2 cascades have been triggered by functioning implanted adv-BMP-2 gene-engineered MSCs in the cranial defect. A recombinant replication-deficient adenovirus successfully mediates human BMP-2 gene transfer and BMP-2 protein expression in the MSCs. Moreover, BMP-2 protein expression is detected in the culture medium of the transduced cell. Adenovirus-mediated BMP-2 gene transfer to MSCs directed cell proliferation and differentiation. This investigation speculates that the cell response to the gene transfer was through an autocrine or paracrine effect of BMP-2 protein that was expressed from the transferred BMP-2 gene by the cell itself. In our previous in vitro study, a one-time MSC infection of recombinant adenovirus demonstrated its ability to induce bone formation until mineralization in 30 days.
11 BMP-2 protein was continuously released while the transferred gene remained in the cell. 30 The length of adenovirus-mediated transgene expression in vivo is varied. For example, the adenovirus vector can be cleared within 2 weeks in the liver and 11 weeks in tendons. [31] [32] [33] [34] No data exist on how long adenovirus control of gene expression needs to be altered to achieve a final effect. It is assumed that BMP-2 produced from gene transfer enhanced the bone repair process. Bone formation combined by an unknown intrinsic mechanism even after the adenovirus vector was cleared out. Analytical results indicated that involvement of genetransferred BMP-2 is necessary because the intrinsic bone repair process may not be powerful enough in the case of large defects, as shown in the control site.
Recombinant adenovirus-mediated gene transfer is limited in immunocompetent hosts. The host immune response to the adenovirus proteins from leak expression of virus genome is to delete the recombinant adenovirus and terminate transgene expression. Furthermore, inflammation has also been observed. The use of a new generation of recombinant adenovirus vectors with less immunogenecity and prolonged expression in the immunocompetent host can help to reduce these problems and increase efficacy.
Developmental biology holds that undifferentiated stem cells follow a definite sequence of cellular alterations and lineage, resulting in a fully differentiated cell with a specific phenotype. [35] [36] [37] Previous literature applied some gene therapies in osteochodral repair on cell lines, 29, 38, 39 that did not follow the principles of tissue engineering and further clinical applications. Gene therapy has been demonstrated to heal small defects in long bones or cranium in rabbits. 29, [38] [39] [40] [41] [42] Optimal biomaterials selected in this investigation enable good maxillary repair. 42, 43 This work demonstrates that BMP-2 gene transfer into MSCs can potentially direct differentiation into bone formation in vivo. Moreover, this work also showed that MSCs/collagen type I with adv BMP-2 gene transfer could enhance bony healing of craniofacial defects. The adenoviral vector was cleared by the host within 3 months in this study, consistent with other reports. [31] [32] [33] [34] This study provides the strongest evidence to date that autologous tissue-engineered membranous bone repair can be achieved by MSCs with adv BMP-2 gene transfer. This evidence can be used to create an alternative treatment for enophthalamus and maxillofacial deformities.
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Materials and methods
Construction of recombinant adenovirus
Adenovirus BMP-2, a replication-defective adenovirus vector containing human BMP-2 gene, was constructed as previously described. 12 Cytomegalovirus early gene promoter/enhancer controls BMP-2 gene transcription in this vector. The recombinant adenovirus containing Escherichia coli lac z gene (adenovirus b-galactosidase) was constructed using the same procedure and served as the control vector in the experiments.
Bone marrow mesenchymal stem cell culture and adenoviral infection
A total of 20 female miniature swine (Mitsae Pig, CGU, Taiwan) were used as the study group. The animals all weighed approximately 15 kg and were 4 months old. Bone marrow was aspirated under anesthesia using i.m. injection of 1 ml/10 kg 2% Rompum (Bayer, USA) and 50 mg/10 kg Ketamine (Yung Shin Pharmaceutical Industrial Co., Taiwan). A volume of 20 ml bone marrow aspirate was gathered from the iliac crest of each animal, and mixed with 2 cm 2 of heparin sodium (5000 U/ml; China Chemical & Pharmaceutical Co., Taiwan). The bone marrow samples were then mixed with 20 ml DMEM medium. The marrow cells were then collected by 1000 rpm spin. Next, the pellet was resuspended with 2.5 ml DMEM medium. The cell suspension was loaded onto 70% Percoll (Sigma, St Louis, MO, USA) gradients and centrifuged at 460 g for 15 min. Centrifuging produced three groups: the top 25% of the gradients (low-density cells), pooled density¼1.03 g/ml; the middle 50% of the gradients (high-density cells), pooled density¼1.10 g/ml; and the bottom 25% of the gradients, pooled density¼1.14 g/ml. MSCs were found in the lowdensity fraction and were collected and plated. Adherent MSCs were cultured in complete DMEM at 371C with 5% CO 2 . The medium was changed every 3-4 days.
MSCs received human BMP-2 gene transfer by infection with recombinant adenovirus BMP-2 at a multiplicity of infection (MOI) of 50. MSCs were infected at 371C overnight and cultured in complete medium for another 5 days. As a control, adenovirus-mediated bGal gene transfer was performed simultaneously under the same conditions. The transduced MSCs were trypsinized by 0.4% trypsin and washed three times using DMEM medium. The cells were then mixed with type I collagen (Pancogene S s , Gattefosse, Saint-Priest, Cedex, France) to achieve a cell concentration of 50 Â 10 6 /ml. After 1 h of incubation at 371C in CO 2 incubator, the cell/collagen type I mixed construct became gel-like.
Western blot detection of adenovirus BMP-2 expression in MSC in vitro
MSCs were grown in DMEM with 10% FBS to 90% confluence in roller bottles. The cells were infected with 20 ml virus working stock (10 7 PFU/ml) of adenovirus bgal or adenovirus BMP-2 at an MOI of 50. The infected cells were then maintained in DMEM with 10% FBS. The conditioned medium was collected 7 days after infection.
A volume of 10 ml mAb against human BMP-2 (R&D systems, Inc., Minneapolis, MN, USA) was added to the 25 ml harvested conditioned medium and incubated at 41C for 2-3 h. Subsequently, 50 ml protein A Sepharose (Amersham Pharmacia Biotech., Piscataway, NJ, USA) was added and rotated overnight. Antigen-Ab-Sepharose complexes were collected after centrifugation at 1500 rpm for 5 min. The pellets were then resuspended in 50 ml 2 Â Laemli buffer and boiled for 5 min. After brief centrifugation, supernatants were run on a 12.5% SDS-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Micron Separations Inc., Westborough, MA, USA). After blocking with 5% BSA solution at room temperature for 1 h, the transferred membrane was exposed to mAb against human BMP-2 in 1% BSA solution overnight. Blots were then reacted with goat anti-mouse IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) in 1% BSA solution for 1 h and developed with enhanced chemiluminesence (Amersham Pharmacia Biotech., Piscataway, NJ, USA).
Open implantation after creating maxillary bone defect
During the second stage of surgery, all miniature swine were intubated and placed on ventilators. Critical size defects were defined as those that do not regenerate spontaneously during the lifespan of the animal. 44, 45 The bilateral infraorbital flaps were elevated to expose the maxilla. Meanwhile, the maxilla bone was sawed and burred out to create an infraorbital rim defect of 3 Â 1.2 cm 2 . No osteoinductive periosteum remained in bilateral maxillary defects. To bridge the defect, one biodegradable PLLA (BioSorb FXt, Bionx Implants Ltd, Tampere, Finland), six-hole miniplate was wired onto both edges of the remaining bony ends of each maxillary defect to provide an internal splint. A volume of 3 ml of collagen type I gel (Pancogen S s , Gattefosse Co., SaintPriest, France)/cell mix construct was also implanted to each defect. The right side defect (on the right of the animal) was covered with BMP-2 gene-transferred MSCs construct. Meanwhile, the left side defect was filled with bgal gene-transferred MSCs construct. Finally, the facial wounds were closed in a watertight manner. The swine were killed at 3 months after the implantation of tissueengineered constructs.
Three-dimensional computer tomography model
Helical scanning was applied to the swine heads. Primary data manipulation was performed in the Radiology Department at a 2-mm thickness, and the raw data were transferred to an IBM-compatible personal computer in the Medical Imaging Laboratory. 46 Reformation of the CT data was performed, setting the voxel unit at 0.6 Â 0.6 Â 0.6 mm. The computer displayed 3D images of the swine heads. A thresholding technique was used to remove the soft tissue, revealing the osseous structures of the swine heads. The regenerated bone was then outlined, and surface area measurement was conducted. Finally, the CT data reformation, image display, and area measurement were performed using the Analyze 4.0 software 47 (Biomedical Imaging Resource, Mayo Foundation, Rochester, MN, USA).
Histological examination of bone samples harvested from the maxillary defects
Harvested samples were fixed in buffered 10% formalin for 72 h and then sawed into two halves. One was decalcified in Decalcifier I (Surgipath, Northbrook, IL, 
Immunohistochemistry for adenovirus hexon protein
Paraffin-embedded samples were examined for adenovirus hexon protein by immunohistochemistry. Meanwhile, embedded tissues were incised after removal from paraffin slides and then hydrated. The rabbit primary antibody (Ab) against adenovirus hexon protein (Chemicon International, Temecule, CA, USA) was applied to the slides at a concentration of 1:500. Slides were incubated at 351C for 1 h. A biotinylated goat anti-rabbit secondary Ab was then applied, followed by a streptavidin-horseradish peroxidase conjugate. Diaminobenzidine (DAB) was used as the chemogen, before slides were counterstained with hematoxylin. 48 
Biomechanical analysis
The samples used for biomechanical analysis were stored at À701C after harvesting. Newly formed bone in the repaired defects was burred and finished to form 6 mm diametric cylinders with a height of 3 mm for compressive testing. Each specimen was then tested to failure under axial compression using an MTS testing machine (Bionix 858, MTS Corp., MN, USA). To ensure perpendicular compression, a 6 mm diametric cylindrical rod with self-aligned function was used as a plunger, and was clamped on the upper side of the MTS wedge grip. Next, the specimen was placed on a flat supporting jig clamped on the lower side of the MTS wedge grip that was connected to a 2500 N load cell. Following specimen positioning, the compressive force was applied at a constant loading of 20 N/s and the relation between force and displacement was recorded in 0.02 mm increments using MTS Teststar software. The maximal compression strength for each individual specimen was determined by dividing the magnitude of maximal force to the minimum original cross-section area carried by the test specimen. 49 Finally, the newly formed bone was compared to the normal maxilla bone.
Statistical analysis
Data are expressed as means7s.d. The paired t-test was employed to assess the statistical significance of the results for all of the 3D CT images of the repaired bone areas. Additionally, the paired t-test was also used to compare the biomechanical properties of the new bone and the normal maxilla.
